Last reviewed · How we verify

NCT05978817

Clinical Effectiveness of Damon Ultima Vs Conventional Brackets Trial)

Status unknown NA Last updated 12 January 2024
What this trial tests

NA trial testing Damon Ultima bracket in Skeletal and Dental CL I Malocclusion Moderate Crowding in 34 participants. Status unknown.

Timeline
1 August 2023
Primary endpoint
1 September 2024
1 May 2025

Quick facts

Lead sponsorUniversity of Baghdad
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment34
Start date1 August 2023
Primary completion1 September 2024
Estimated completion1 May 2025
Sites1 location across Iraq

Drugs / interventions tested

Conditions studied

Sponsor

University of Baghdad

Who can join

Adults 15 to 35, any sex, with Skeletal and Dental CL I Malocclusion Moderate Crowding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Compare the clinical performance, root resorption and pain perception between passive self-ligating Damon Ultema vs conventional brackets.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Baghdad trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05978817.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing